<p><a href="http://news.yahoo.com/cancer-drugs-tamiflu-lift-roche-first-quarter-sales-055112666.html"><img src="http://l.yimg.com/bt/api/res/1.2/HGw2YCWRSWhcSJyoY7ymxA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-04-11T055112Z_1_CBRE93A0GA400_RTROPTP_2_ROCHE.JPG" width="130" height="86" alt="The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf" align="left" title="The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf" border="0" /></a>By Ben Hirschler LONDON (Reuters) - A spike in U.S. demand for flu drug Tamiflu and strong sales of mainstay cancer medicines lifted first-quarter sales at Roche Holding AG by a bigger-than-expected 5 percent. The healthy performance in its main pharmaceuticals unit - which was also bolstered by approval of two new breast cancer drugs - offset weak sales in diagnosticSource: http://rss.news.yahoo.com/rss/cancer
opm passover Florida Gulf Coast University Aaron Craft school closings powerball ariana grande
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.